UFP Technologies Inc. Insider Trading

UFPT

Last 12 months

Insiders sold $14M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Executive Chairman R Jeffrey Bailly sold $5M on Aug 7, 55% of their stake, outside a plan. The last open-market buy by an executive or director was in Feb 2025.

Net open-market

−$14M

0 buys · 11 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

Feb 2025

Feb 27, 2025

Get an email when UFPT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 25	Marc D Kozin Director	SoldNo plan 2 parts	7,000	$304.50 average	$2.13M	25%	Form 4
Aug 18	Symeria Hudson Director	SoldNo plan	298	$319.11	95K	24%	Form 4
Aug 14	Symeria Hudson Director	SoldNo plan	1,926	$324.58	625K	61%	Form 4
Aug 13	Cynthia L Feldmann Director	SoldNo plan	1,000	$324.26	324K	18%	Form 4
Aug 10	R Jeffrey Bailly Executive Chairman	SoldNo plan 3 parts	13,011	$316.13 average	$4.11M	100%	Form 4
Aug 6 – 7	R Jeffrey Bailly Executive Chairman	SoldNo plan 4 parts	15,695	$318.38 average	$5M	55%	Form 4
Aug 6	Jason Holt Vice President	SoldNo plan	1,100	$317.00	349K	12%	Form 4
Jun 12	Cynthia L Feldmann Director	SoldNo plan 2 parts	1,200	$239.29 average	287K	18%	Form 4
May 12	Daniel C Croteau Director	SoldNo plan	2,864	$221.71	635K	77%	Form 4
Dec 10, 2025	Jason Holt Vice President	SoldNo plan	100	$213.58	21K	1.3%	Form 4
Nov 6, 2025	Christopher P. Litterio Senior Vice President	SoldNo plan 10 parts	1,829	$227.20 average	416K	15%	Form 4
Sep 5, 2025	Daniel C Croteau Director	SoldNo plan 2 parts	2,873	$206.02 average	592K	77%	Form 4
May 8, 2025	Christopher P. Litterio Senior Vice President	SoldNo plan 2 parts	1,473	$220.12 average	324K	10%	Form 4
Feb 28, 2025	Cynthia L Feldmann Director	SoldNo plan 2 parts	2,756	$230.72 average	636K	40%	Form 4
Feb 27, 2025	Daniel C Croteau Director	SoldNo plan 8 parts	6,846	$228.41 average	$1.56M	79%	Form 4
Feb 27, 2025	Ronald J Lataille Chief Financial Officer	Bought	400	$229.09	92K	2.7%	Form 4
Nov 12, 2024 – Nov 13, 2024	R Jeffrey Bailly CEO	SoldNo plan 11 parts	15,021	$346.34 average	$5.2M	34%	Form 4
Nov 12, 2024	Jason Holt Vice President	SoldNo plan	146	$342.69	50K	2.1%	Form 4
Nov 11, 2024	Symeria Hudson Director	SoldNo plan 3 parts	2,293	$340.83 average	782K	81%	Form 4
Nov 8, 2024 – Nov 11, 2024	R Jeffrey Bailly CEO	SoldNo plan 11 parts	25,416	$348.40 average	$8.85M	37%	Form 4
Nov 8, 2024	Cynthia L Feldmann Director	SoldNo plan	647	$352.30	228K	14%	Form 4

Aug 25No plan
Marc D Kozin
Director · sold 7,000 at avg $304.50
$2.13M
25% of stake
Aug 18No plan
Symeria Hudson
Director · sold 298 at $319.11
95K
24% of stake
Aug 14No plan
Symeria Hudson
Director · sold 1,926 at $324.58
625K
61% of stake
Aug 13No plan
Cynthia L Feldmann
Director · sold 1,000 at $324.26
324K
18% of stake
Aug 10No plan
R Jeffrey Bailly
Executive Chairman · sold 13,011 at avg $316.13
$4.11M
100% of stake
Aug 6 – 7No plan
R Jeffrey Bailly
Executive Chairman · sold 15,695 at avg $318.38
$5M
55% of stake
Aug 6No plan
Jason Holt
Vice President · sold 1,100 at $317.00
349K
12% of stake
Jun 12No plan
Cynthia L Feldmann
Director · sold 1,200 at avg $239.29
287K
18% of stake
May 12No plan
Daniel C Croteau
Director · sold 2,864 at $221.71
635K
77% of stake
Dec 10, 2025No plan
Jason Holt
Vice President · sold 100 at $213.58
21K
1.3% of stake
Nov 6, 2025No plan
Christopher P. Litterio
Senior Vice President · sold 1,829 at avg $227.20
416K
15% of stake
Sep 5, 2025No plan
Daniel C Croteau
Director · sold 2,873 at avg $206.02
592K
77% of stake
May 8, 2025No plan
Christopher P. Litterio
Senior Vice President · sold 1,473 at avg $220.12
324K
10% of stake
Feb 28, 2025No plan
Cynthia L Feldmann
Director · sold 2,756 at avg $230.72
636K
40% of stake
Feb 27, 2025No plan
Daniel C Croteau
Director · sold 6,846 at avg $228.41
$1.56M
79% of stake
Feb 27, 2025
Ronald J Lataille
Chief Financial Officer · bought 400 at $229.09
92K
2.7% of stake
Nov 12, 2024 – Nov 13, 2024No plan
R Jeffrey Bailly
CEO · sold 15,021 at avg $346.34
$5.2M
34% of stake
Nov 12, 2024No plan
Jason Holt
Vice President · sold 146 at $342.69
50K
2.1% of stake
Nov 11, 2024No plan
Symeria Hudson
Director · sold 2,293 at avg $340.83
782K
81% of stake
Nov 8, 2024 – Nov 11, 2024No plan
R Jeffrey Bailly
CEO · sold 25,416 at avg $348.40
$8.85M
37% of stake
Nov 8, 2024No plan
Cynthia L Feldmann
Director · sold 647 at $352.30
228K
14% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch UFPT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with UFPT

CompareIntrinsic value

GKOSGlaukos Corporation

$246.70+5.86%55

BVSBioventus Inc.

$11.42+4.34%66

ATRCAtriCure, Inc.

$65.53+8.48%65

NVCRNovoCure Ltd.

$14.61+8.79%24

AORTArtivion Inc.

$26.45+11.56%29

ATECAlphatec Holdings Inc.

$8.28+10.84%45

IRTCIrhythm Technologies Inc.

$134.00+6.04%45

OFIXOrthofix Medical Inc.

$9.72+10.96%18

Held by ETFs

UFPT is in 62 US ETFs. The largest of them, with UFPT's weight in each:

Spot a number that looks wrong? Check it in UFPT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing UFPT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.